Sanofi Nexviazyme Delivers Positive Phase 3 Pompe Trial Results
PARIS, June 30, 2026 Sanofi has announced that its enzyme replacement therapy Nexviazyme® (avalglucosidase alfa) successfully met all primary...
European Commission
Advertisement
Zambon Hopledo® Wins CHMP Backing for Parkinson’s Disease
BRESSO, Milan, Italy, June 29, 2026 Zambon has announced that the Committee for Medicinal Products for Human Use (CHMP)...
Roche Enspryng Gains FDA Priority Review for TED Treatment
BASEL, Switzerland, June 30, 2026 Roche has announced that the U.S. Food and Drug Administration (FDA) has granted Priority...
AbbVie RINVOQ® Moves Closer to EU Approval for Alopecia Areata
NORTH CHICAGO, Ill., June 29, 2026 AbbVie has announced that the European Medicines Agency’s Committee for Medicinal Products for...
Daiichi Sankyo and AstraZeneca Secure EU Enhertu Approval
TOKYO, June 29, 2026 Daiichi Sankyo and AstraZeneca have announced that the European Commission (EC) has approved Enhertu® (trastuzumab...
Advertisements
Acadia’s DAYBU Recommended for EU Approval in Rett Syndrome
SAN DIEGO, June 26, 2026 Acadia Pharmaceuticals announced that the Committee for Medicinal Products for Human Use (CHMP) of...
AstraZeneca, Daiichi Sankyo Advance Datroway Toward EU Approval
CAMBRIDGE, UK & TOKYO, Japan, June 26, 2026 AstraZeneca and Daiichi Sankyo have moved one step closer to expanding...
Lilly Jaypirca CHMP Backs EU Approval for CLL Treatment
INDIANAPOLIS, June 26, 2026 Eli Lilly and Company announced that the European Medicines Agency’s Committee for Medicinal Products for...
AbbVie Secures EU Approval for MAVIRET in Acute Hepatitis C
NORTH CHICAGO, Ill., June 23, 2026 AbbVie announced that the European Commission has approved MAVIRET® (glecaprevir/pibrentasvir) for the treatment...
Sanofi Wins EU Approval for Sarclisa SC in Multiple Myeloma
PARIS, France, June 8, 2026 Sanofi announced that the European Commission has approved Sarclisa® (isatuximab) subcutaneous (SC) for the...
Advertisement
